Back

Determinants and prognostic impact of afterload mismatch after MitraClip implantation

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Chronic heart failure - HFpEF - HFrEF - HFmREF Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Filippo Angelini

Hospital Citta Della Salute e della Scienza di Torino, Turin (Italy)

5 More presentations in this session

Presentation thumbnail
Impact of age on the utility of CardioMEMs device to guide heart failure therapy: analysis of the National Readmissions Database
Assistant Professor A. Briasoulis (Athens, GR)
Abstract Slides
Presentation thumbnail
Heart failure with mildly reduced ejection fraction: not a mid-range prognosis
Doctor J. Borges-Rosa (Coimbra, PT)
Abstract Slides
Presentation thumbnail
The prognostic value of sleep disordered breathing and the hypoxemic burden in HFpEF patients
Miss S. Mourmans (Maastricht, NL)
Abstract Slides
Presentation thumbnail
Quality of life (QoL) in patients with heart failure with preserved ejection fraction (HFpEF): a systematic review
Doctor J. Chen (Gaithersburg, US)
Abstract Slides
Presentation thumbnail
Systemic microvascular response to insulin is associated with risk of heart failure with preserved ejection fraction in women with type 2 diabetes
Doctor E. Dal Canto (Utrecht, NL)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - HFpEF - HFrEF - HFmREF

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources